🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Placebo Dry Powder Inhaler (DPI)

Found 83 matching trials

Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE2

Batefenterol is a novel bifunctional molecule that combines muscarinic anta...

Status

Completed

Location

GSK Investigational Site

Start Date

2015-11-06

Trial ID

NCT02570165

Treatments Being Tested

Batefenterol Umeclidinium/ Vilanterol Placebo

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7594 Inhaled Formulation in Healthy Japanese Men

PHASE1

This is a randomized, single-blind, placebo-controlled, sequential-group st...

Status

Completed

Location

Research Site

Start Date

2016-01-12

Trial ID

NCT02645253

Treatments Being Tested

AZD7594 inhalation powder (200 μg)AZD7594 inhalation powder (400 μg)AZD7594 pressurized inhalation suspension (200 μg)AZD7594 placebo inhalation powder AZD7594 placebo pressurized inhalation suspension

Efficacy of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) (CHF 5993)Administered Via Dry Powder Inhaler (DPI) in Chronic Obstructive Pulmonary Disease (COPD)

PHASE2

The purpose of this study is to evaluate the efficacy of Fixed Combination ...

Status

Completed

Location

Medical Center Convex EOOD

Start Date

2018-06-15

Trial ID

NCT03590379

Treatments Being Tested

CHF 5993 DPI CHF5993 pMDI CHF 1535 pMDI Placebo DPI Placebo pMDI

A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

PHASE3

This study is a 12-week, multicenter, randomized, double blind, parallel gr...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-09-01

Trial ID

NCT02152605

Treatments Being Tested

UMEC/VI Placebo

Formoterol Dose Ranging Study (ACHIEVE Duaklir USA Phase IIb)

PHASE2

To assess the bronchodilation of three doses of formoterol fumarate (6 μg, ...

Status

Completed

Location

Research Site

Start Date

2016-06-30

Trial ID

NCT02796651

Treatments Being Tested

Formoterol fumarate (6 μg)Formoterol furmarate (20 μg)Placebo for formoterol fumarate Formoterol fumarate (12 μg)Formoterol fumarate (40 μg)

A Comparison of Critical Errors, Overall Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA Versus BREEZHALER Dry Powder Inhalers (DPIs) in Adult Participants With Asthma

PHASE4

This study aims to provide data in adult participants with mild to moderate...

Status

Completed

Location

GSK Investigational Site

Start Date

2021-04-14

Trial ID

NCT04813354

Treatments Being Tested

ELLIPTA BREEZHALER

Comparative Study of ELLIPTA Dry Powder Inhaler (DPI) Versus DISKUS DPI Used With HandiHaler DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

PHASE4

This randomized, cross over study aims to find out the benefits of deliveri...

Status

Completed

Location

GSK Investigational Site

Start Date

2017-09-20

Trial ID

NCT03227445

Treatments Being Tested

ELLIPTA placebo DPI DISKUS placebo DPI HandiHaler placebo DPI Inhaler preference questionnaires

Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance Therapy

PHASE2

The purpose of this study is to evaluate the efficacy and safety of CHF6001...

Status

Terminated

Location

Site 032020 - Instituto Especialidades de la Salud Rosario - Clinica del Torax

Start Date

2023-11-26

Trial ID

NCT06029595

Treatments Being Tested

Experimental: CHF6001 3200 μg Placebo Comparator: CHF6001 Placebo

Efficacy and Safety of Inhaled AZD1402 Administered for Four Weeks in Adults With Asthma on Medium-to-High Dose Inhaled Corticosteroids

PHASE2

This is a randomised, placebo-controlled, double-blinded, multi-centre, 2-p...

Status

Terminated

Location

Research Site

Start Date

2021-03-12

Trial ID

NCT04643158

Treatments Being Tested

AZD1402 Placebo Short acting beta agonist (SABA) (rescue medication)Run-in medications (ICS-LABA combination)

Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418)

PHASE4

This is a randomized, multi-center, parallel-group, active-controlled, doub...

Status

Completed

Location

Multiple Locations

Start Date

2006-09

Trial ID

NCT00394355

Treatments Being Tested

mometasone furoate dry powder inhaler mometasone furoate dry powder inhaler fluticasone propionate hydrofluoroalkane (HFA)montelukast

Previous Next